MWP
REGN icon

MYCIO Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

MYCIO Wealth Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-754
Closed -$277K – 255
2016
Q4 		$277K Hold
754
– – 0.04% 168
2016
Q3 		$303K Sell
754
-280
-27% -$112K 0.05% 133
2016
Q2 		$361K Buy
1,034
+742
+254% +$286K 0.06% 116
2016
Q1 		$105K Buy
+292
New +$120K 0.02% 226
2015
Q4 		– Sell
-1
Closed – – 804
2015
Q3 		$0 Buy
+1
New +$537 ﹤0.01% 936

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

MYCIO Wealth Partners's REGN Position: Q1 2017 in Review

MYCIO Wealth Partners sold out of Regeneron Pharmaceuticals (REGN) in Q1 2017, closing a stake of 754 shares — an estimated $277K sold.

MYCIO Wealth Partners first reported a position in REGN in Q3 2015 and held it in 5 quarters. The position peaked at $361K in Q2 2016. 579 funds tracked by Wall St. Rank hold REGN as of Q1 2017.

  • MYCIO Wealth Partners reported no remaining Regeneron Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • MYCIO Wealth Partners sold 754 Regeneron Pharmaceuticals shares in Q1 2017, an estimated $277K.
  • MYCIO Wealth Partners first reported a position in Regeneron Pharmaceuticals in Q3 2015 and held it in 5 quarters.
  • MYCIO Wealth Partners's Regeneron Pharmaceuticals position peaked at $361K in Q2 2016.
  • 579 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2017.

Based on MYCIO Wealth Partners's 13F filing for Q1 2017, filed 25 Apr 2017.